SEMA3A-mediated crosstalk between prostate cancer cells and tumor-associated macrophages promotes androgen deprivation therapy resistance.
作者信息
Liu Fei, Wang Chao, Huang Hai, Yang Yue, Dai Lihe, Han Sujun, Xing Nianzeng, Ren Shancheng
机构信息
Department of Urology, Shanghai Changhai Hospital, Shanghai, China.
Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
出版信息
Cell Mol Immunol. 2021 Mar;18(3):752-754. doi: 10.1038/s41423-021-00637-4. Epub 2021 Feb 8.
Abstract
摘要
相似文献
1
SEMA3A-mediated crosstalk between prostate cancer cells and tumor-associated macrophages promotes androgen deprivation therapy resistance.SEMA3A介导的前列腺癌细胞与肿瘤相关巨噬细胞之间的串扰促进雄激素剥夺治疗耐药性。
Cell Mol Immunol. 2021 Mar;18(3):752-754. doi: 10.1038/s41423-021-00637-4. Epub 2021 Feb 8.
2
Physalins A and B inhibit androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor expression.豆甾烷类 A 和 B 通过激活细胞凋亡和下调雄激素受体表达来抑制雄激素非依赖性前列腺癌细胞生长。
Biol Pharm Bull. 2011;34(10):1584-8. doi: 10.1248/bpb.34.1584.
3
Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression.恩杂鲁胺的雄激素剥夺疗法通过降低 EPHB6 抑制物的表达促进前列腺癌转移。
Cancer Lett. 2017 Nov 1;408:155-163. doi: 10.1016/j.canlet.2017.08.014. Epub 2017 Aug 18.
4
UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications.UHRF1 通过 KDM4C 介导的染色质修饰促进雄激素受体调节的 CDC6 转录和抗雄激素受体药物耐药性在前列腺癌中。
Cancer Lett. 2021 Nov 1;520:172-183. doi: 10.1016/j.canlet.2021.07.012. Epub 2021 Jul 12.
5
Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages.指导分子 SEMA3A 通过差异化调节肿瘤相关巨噬细胞的增殖来限制肿瘤生长。
Cancer Res. 2016 Jun 1;76(11):3166-78. doi: 10.1158/0008-5472.CAN-15-2596. Epub 2016 Apr 6.
6
Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.轴突导向因子信号素3A与胰腺癌不良预后的关联
Int J Cancer. 2007 Dec 1;121(11):2421-33. doi: 10.1002/ijc.22949.
7
Independence of HIF1a and androgen signaling pathways in prostate cancer.前列腺癌中 HIF1a 和雄激素信号通路的独立性。
BMC Cancer. 2020 May 25;20(1):469. doi: 10.1186/s12885-020-06890-6.
8
Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity.爱德弗辛通过增加ATF3和抑制雄激素受体活性促进去势前列腺肿瘤细胞凋亡。
Mol Cancer Ther. 2016 Jun;15(6):1353-63. doi: 10.1158/1535-7163.MCT-15-0332. Epub 2016 Mar 4.
9
Differential expression of the semaphorin 3A pathway in prostatic cancer.信号素 3A 通路在前列腺癌中的差异表达。
Histopathology. 2009 Oct;55(4):392-8. doi: 10.1111/j.1365-2559.2009.03406.x.
10
MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells.MicroRNA-145 转录调控前列腺癌细胞中 Semaphorin 3A 的表达。
Cell Biol Int. 2021 May;45(5):1082-1090. doi: 10.1002/cbin.11554. Epub 2021 Feb 4.
引用本文的文献
1
Knocking down hypoxia-induced Semaphorin 6B may attenuate the progression of cervical cancer through regulating macrophage M2 polarization.敲低缺氧诱导的信号素6B可能通过调节巨噬细胞M2极化来减弱宫颈癌的进展。
J Transl Med. 2025 Jul 10;23(1):776. doi: 10.1186/s12967-025-06692-z.
2
GATA2 up-regulation restores androgen receptor chromatin association and advances darolutamide resistance in prostate cancer.GATA2上调可恢复雄激素受体与染色质的结合并促进前列腺癌对达洛鲁胺耐药。
Genes Dis. 2024 Dec 28;12(4):101508. doi: 10.1016/j.gendis.2024.101508. eCollection 2025 Jul.
3
Inhibition of Semaphorin 3A in Hippocampus Alleviates Postpartum Depression-Like Behaviors in Mice.抑制小鼠海马体中的信号素3A可减轻产后抑郁样行为。
Mol Neurobiol. 2025 Jun;62(6):7723-7737. doi: 10.1007/s12035-025-04752-5. Epub 2025 Feb 11.
4
Human intermediate prostate cancer stem cells contribute to the initiation and development of prostate adenocarcinoma.人前列腺中端癌细胞促进前列腺腺癌的发生和发展。
Stem Cell Res Ther. 2024 Sep 11;15(1):296. doi: 10.1186/s13287-024-03917-8.
5
Expression of semaphorin 3A (SEMA3A) in breast cancer subtypes.信号蛋白 3A（SEMA3A）在乳腺癌亚型中的表达。
Sci Rep. 2024 Jan 23;14(1):1969. doi: 10.1038/s41598-024-51796-z.
6
Semaphorins and Their Roles in Breast Cancer: Implications for Therapy Resistance.Semaphorins 及其在乳腺癌中的作用：对治疗耐药性的影响。
Int J Mol Sci. 2023 Aug 23;24(17):13093. doi: 10.3390/ijms241713093.
7
Sema3A Alleviates the Malignant Behaviors of Gastric Cancer Cells by Inhibiting NRP-1.Sema3A 通过抑制 NRP-1 减轻胃癌细胞的恶性行为。
Curr Mol Med. 2024;24(7):931-939. doi: 10.2174/1566524023666230801124826.
8
Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.前列腺肿瘤微环境的景观和相关治疗靶点的研究进展。
Acta Biochim Biophys Sin (Shanghai). 2023 Jun 9;55(6):956-973. doi: 10.3724/abbs.2023092.
9
Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors.癌症患者接受免疫检查点抑制剂治疗后的急性肾损伤风险比较。
Cancer Commun (Lond). 2023 Feb;43(2):214-224. doi: 10.1002/cac2.12396. Epub 2022 Dec 17.
10
Association between SEMA3A signaling pathway genes and BMD/OP risk: An epidemiological and experimental study.SEMA3A 信号通路基因与 BMD/OP 风险的关联：一项流行病学和实验研究。
Front Endocrinol (Lausanne). 2022 Nov 8;13:1014431. doi: 10.3389/fendo.2022.1014431. eCollection 2022.
Zotero 插件